journal
Journals Endocrinology and Metabolism C...

Endocrinology and Metabolism Clinics of North America

https://read.qxmd.com/read/38272603/the-evolving-landscape-of-type-1-diabetes-management
#1
EDITORIAL
Osagie Ebekozien
No abstract text is available yet for this article.
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272602/type-1-diabetes
#2
EDITORIAL
Robert Rapaport
No abstract text is available yet for this article.
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272601/social-determinants-of-health-screening-in-type-1-diabetes-management
#3
REVIEW
Nana-Hawa Yayah Jones, India Cole, Kelsey J Hart, Sarah Corathers, Shivani Agarwal, Ori Odugbesan, Osagie Ebekozien, Manmohan K Kamboj, Michael A Harris, Kathryn L Fantasia, Mona Mansour
Type 1 diabetes management is intricately influenced by social determinants of health. Economic status impacts access to vital resources like insulin and diabetes technology. Racism, social injustice, and implicit biases affect equitable delivery of care. Education levels affect understanding of self-care, leading to disparities in glycemic outcomes. Geographic location can limit access to health care facilities. Stressors from discrimination or financial strain can disrupt disease management. Addressing these social factors is crucial for equitable diabetes care, emphasizing the need for comprehensive strategies that go beyond medical interventions to ensure optimal health outcomes for all individuals with type 1 diabetes...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272600/emerging-technologies-and-therapeutics-for-type-1-diabetes
#4
REVIEW
Halis Kaan Akturk, Alexis M McKee
Recent years witnessed advancements in diabetes technologies and therapeutics. People with type 1 diabetes have more options to control their blood glucose, prevent hypoglycemia, and spend more time with their loved ones. Newer diabetes technologies and therapeutics improve the quality of life and boost the confidence of people with type 1 diabetes. In parallel to changes in the diabetes technology field, stem cell research has been evolving. Gene editing and production of β cells from stem cells are ongoing...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272599/optimizing-glycemic-outcomes-for-minoritized-and-medically-underserved-adults-living-with-type-1-diabetes
#5
REVIEW
Devin W Steenkamp, Kathryn L Fantasia, Howard A Wolpert
Individuals living with type 1 diabetes (T1D) from medically underserved communities have poorer health outcomes. Efforts to improve outcomes include a focus on team-based care, activation of behavior change, and enhancing self-management skills and practices. Advanced diabetes technologies are part of the standard of care for adults with T1D. However, health care providers often carry implicit biases and may be uncomfortable with recommending technologies to patients who have traditionally been excluded from efficacy trials or have limited real-world exposure to devices...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272598/incorporating-the-six-core-elements-of-health-care-transition-in-type-1-diabetes-care-for-emerging-adults
#6
REVIEW
Faisal S Malik, Kathryn W Weaver, Sarah D Corathers, Patience H White
A growing body of literature finds persistent problems in the provision of recommended health care transition services, as well as adverse outcomes associated with the lack of these services in emerging adults with type 1 diabetes. The Six Core Elements of Health Care Transition offers a structured approach to the phases of health care transition support for both pediatric and adult diabetes practices. This article reviews strategies to incorporate the Six Core Elements into ambulatory diabetes care to support successful health care transition for emerging adults with type 1 diabetes...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272597/young-adults-with-type-1-diabetes
#7
REVIEW
Priyanka Mathias, Sarah D Corathers, Samantha A Carreon, Marisa E Hilliard, Jaclyn L Papadakis, Jill Weissberg-Benchell, Jennifer K Raymond, Elizabeth A Pyatak, Shivani Agarwal
Young adults experience multiple developmental transitions across social, educational, vocational, residential, and financial life domains. These transitions are potential competing priorities to managing a chronic condition such as type 1 diabetes and can contribute to poor psychosocial and medical outcomes. In this narrative review, we describe population outcomes of young adult populations and the unique considerations associated with managing type 1 diabetes in young adulthood. We provide an overview of the current evidence-based strategies to improve care for young adults with type 1 diabetes and recommendations for future directions in the field...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272596/optimizing-glycemic-outcomes-for-children-with-type-1-diabetes
#8
REVIEW
Vickie Wu, Lauryn Choleva, Meredith Wilkes
Changes in physical growth, neurocognitive development, and pubertal maturation are some of the challenges to achieving blood glucose targets in children with type 1 diabetes mellitus. To optimize glycemic outcomes, a comprehensive approach is crucial to address psychosocial needs, expand the use of diabetes technology, and diminish health inequities.
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272595/type-1-diabetes-screening-and-diagnosis
#9
REVIEW
Patricia Gomez, Janine Sanchez
Those with concerning signs or symptoms should be evaluated for type 1 diabetes (T1D). Those with first-degree relatives with T1D or based on the presence of high-risk genes are at increased risk and benefit from screening. Universal screening should be considered in light of new potential therapies to delay disease progression. Although oral glucose tolerance test is the gold standard for T1D staging, there are multiple tools available when oral glucose tolerance test is not feasible. Risk score calculations increase the ability to predict disease progression...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272594/stakeholder-engagement-in-type-1-diabetes-research-quality-improvement-and-clinical-care
#10
REVIEW
Nicole Rioles, Christine March, Cynthia E Muñoz, Jeniece Ilkowitz, Amy Ohmer, Risa M Wolf
The integration of stakeholder engagement (SE) in research, quality improvement (QI), and clinical care has gained significant traction. Type 1 diabetes is a chronic disease that requires complex daily management and care from a multidisciplinary team across the lifespan. Inclusion of key stakeholder voices, including patients, caregivers, health care providers and community advocates, in the research process and implementation of clinical care is critical to ensure representation of perspectives that match the values and goals of the patient population...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272593/type-1-diabetes-and-cardiovascular-health
#11
REVIEW
Maria Pesantez, Osagie Ebekozien, Francesco Vendrame
Type 1 diabetes (T1D) is associated with an increased risk of cardiovascular disease (CVD). CVD occurs much earlier in people with T1D than in the general population, and several risk factors have been identified some of which are modifiable. Risk prediction models and imaging tests to detect early signs of CVD have not been extensively validated. Strategies to promote cardiovascular health (CVH) in T1D include identifying risk factors, early treatment to achieve CVH targets, and improving the education of health care providers and people with T1D...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272592/type-1-and-covid-19-diagnosis-clinical-care-and-health-outcomes-during-the-pandemic
#12
REVIEW
Emily Breidbart, Mary Pat Gallagher
The coronavirus disease 2019 (COVID-19) pandemic disrupted health care, creating challenges for people with diabetes and health care systems. Diabetes was recognized as a risk factor for severe disease early in the pandemic. Subsequently, risk factors specific for people with type 1 diabetes were identified, including age, hemoglobin A1c level, and lack of continuous glucose monitoring . Telemedicine, especially when accompanied by diabetes data, allowed effective remote care delivery. However, pre-existing racial disparities in access to diabetes technology persisted and were associated with worse outcomes...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272591/acute-and-chronic-adverse-outcomes-of-type-1-diabetes
#13
REVIEW
Rachel Longendyke, Jody B Grundman, Shideh Majidi
Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy. The pathophysiology of microvascular complications is complex. Hyperglycemia is a common underlying risk factor, underscoring the importance of optimizing glycemic management. Patients with type 1 diabetes are also at increased risk of macrovascular complications including coronary artery disease and vascular disease...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272590/psychosocial-care-for-youth-with-type-1-diabetes-summary-of-reviews-to-inform-clinical-practice
#14
REVIEW
Jenna B Shapiro, Kimberly P Garza, Marissa A Feldman, Madeleine C Suhs, Julia Ellis, Amanda Terry, Kelsey R Howard, Jill Weissberg-Benchell
The intensive demands of diabetes care can be difficult for youth with type 1 diabetes and their families to integrate into daily life. Standards of care in pediatric diabetes highlight the importance of evidence-based psychosocial interventions to optimize self-management behaviors and psychological well-being. The current review summarizes select systematic reviews and meta-analyses on evidence-based behavioral health interventions in pediatric diabetes. Interventions include strategies to strengthen youth psychosocial skills, improve family dynamics and caregiver mental health, enhance health and mental health equity, and address psychosocial factors related to diabetes technology use...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272589/improving-outcomes-for-people-with-type-1-diabetes-through-collaboration-summary-of-type-1-diabetes-exchange-quality-improvement-collaborative-studies
#15
REVIEW
Osagie Ebekozien, Ann Mungmode, Holly Hardison, Robert Rapaport
Type 1 diabetes (T1D) management has evolved over the last decade. Innovations and groundbreaking research have paved the way for improved outcomes for people with T1D. One of the major T1D focused research network that has supported real-world research studies in the United States is the T1D Exchange Quality Improvement Collaborative (T1DX-QI) Network.T1DX-QI is a large multicenter network of 55 T1D clinics that uses quality improvement, health equity framework, and population health principles to improve outcomes for people with T1D...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865486/recognizing-and-addressing-health-inequities-in-endocrinology-and-diabetes
#16
EDITORIAL
Sherita Hill Golden, Rana Malek
No abstract text is available yet for this article.
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865485/disparities-in-endocrinology-care
#17
EDITORIAL
Robert Rapaport
No abstract text is available yet for this article.
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865484/hormonal-injustice-environmental-toxicants-as-drivers-of-endocrine-health-disparities
#18
REVIEW
Margaret C Weiss, Luyu Wang, Robert M Sargis
The toll of multiple endocrine disorders has increased substantially in recent decades, and marginalized populations bear a disproportionate burden of disease. Because of the significant individual and societal impact of these conditions, it is essential to identify and address all modifiable risk factors contributing to these disparities. Abundant evidence now links endocrine dysfunction with exposure to endocrine-disrupting chemicals (EDCs), with greater exposures to multiple EDCs occurring among vulnerable groups, such as racial/ethnic minorities, those with low incomes, and others with high endocrine disease burdens...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865483/sociodemographic-factors-in-pituitary-adenomas
#19
REVIEW
Adriana G Ioachimescu
Pituitary adenomas have been increasingly detected in recent years, especially in the older population. Black patients have a higher incidence than other racial groups. In patients with functioning tumors, presentation and comorbidities are influenced by age and sex, whereas the impact of ethnoracial background is unclear. Active surveillance recommendation and surgery refusal disproportionally affect Black and older patients. The likelihood of surgery at high-volume centers is lower for patients of Black or Hispanic background, uninsured or with lower socioeconomic status...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865482/disparities-in-access-to-high-volume-surgeons-and-specialized-care
#20
REVIEW
Terry P Gao, Rebecca L Green, Lindsay E Kuo
The significant volume-outcome relationship has triggered interest in improving quality of care by directing patients to high-volume centers and surgeons. However, significant disparities exist for different racial/ethnic, geographic, and socioeconomic groups for thyroid, parathyroid, adrenal, and pancreatic neuroendocrine surgical diseases disease.
December 2023: Endocrinology and Metabolism Clinics of North America
journal
journal
29717
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.